Clinical Research Directory
Browse clinical research sites, groups, and studies.
EUS-guided RFA for Pancreatic Neoplasms
Sponsor: Chinese University of Hong Kong
Summary
Radiofrequency ablation has been used for treatment of solid neoplasms of the liver, lung, kidney and adrenal. Recently, EUS-guided RFA has become available and the device allows EUS-guided treatment of pancreatic neoplasms. The procedure has been shown to be feasible in the porcine pancreas and was used to treat small groups of patients that are not suitable for surgery suffering from pancreatic neoplasms. The aim of the current study is to perform a multi-center prospective study on EUS-guided radiofrequency ablation (RFA) of solid pancreatic neoplasms. The hypothesis is that EUS-guided RFA is safe, feasible and effective for treating solid pancreatic neoplasms.
Official title: Multi-center Prospective Study on EUS-guided Radiofrequency Ablation for Solid Pancreatic Neoplasms
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2016-08
Completion Date
2027-05
Last Updated
2026-03-20
Healthy Volunteers
Yes
Conditions
Interventions
EUS-guided RFA
EUS-guided RFA would be performed using a 19-gauge RFA electrode and a generator
Locations (1)
Department of Surgery, Prince of Wales Hospital
Hong Kong, Hong Kong